Our Stories

Reset filter
Q1 2026 Earnings hightlights, Listen to the AI - powered call summary

Teva in Q1 2026: Our transformation at a glance
Teva scientist interacting with a large green abstract network graphic illustrating biological pathways and potential pathways for business growth.

Sustaining Teva’s Generics Powerhouse in the Acceleration Phase
Teva scientist using microscope working on research for innovative medicines

Step Up Innovation
Teva scientist looking at stylized DNA strand representing acceleration phase of pivot to growth strategy

Pivot to Growth: The Acceleration Phase
Female Teva scientist reflecting on how innovative medicines in growth engine therapeutic areas will help patients worldwide

Delivering on Growth Engines
podcast

Teva in 2025: Innovation drives third consecutive year of growth

Pivot to Growth: The Teva Journey